Ustekinumab in psoriasis: Five‐year real life experience from a single tertiary centre
Author:
Affiliation:
1. Department of Dermatology Eskisehir Osmangazi University Faculty of Medicine Eskisehir Turkey
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13224
Reference21 articles.
1. Effectiveness and safety of ustekinumab 90 mg in patients weighing 100 kg or less: a retrospective, observational, multicenter study
2. Ustekinumab treatment for moderate to severe psoriasis. Eight-year real-world follow-up of 61 cases in a tertiary level hospital
3. Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
4. Psoriasis and Obesity
5. Review of safety and efficacy of approved systemic psoriasis therapies
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A real life experience with ustekinumab: The effectiveness of 45 mg on patients greater than 80 kg but lower than 100 kg;Dermatologic Therapy;2022-04-10
2. Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis;Italian Journal of Dermatology and Venereology;2022-03
3. Long‐term efficacy and safety of ustekinumab for moderate‐to‐severe psoriasis: A 9‐year real‐life experience from a tertiary referral center in Turkey;Dermatologic Therapy;2021-07
4. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations;Journal of the European Academy of Dermatology and Venereology;2021-02
5. Ustekinumab;Reactions Weekly;2020-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3